ARCHIVES

FDA Advisors: DepoCyt May Test Accelerated Approval Mechanism

This article is from The Cancer Letter archive.

Vol. 24 No. 45 | November 27, 1998

Download PDF Visit The Full Archive

Related Articles

Provenge Prolonged Prostate Cancer Survival By Seven Months, Study Finds

September 26, 2003

Who Writes NCI’s bypass Budget anyway>? Editor’s name Revealed

May 14, 1993

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

April 5, 1985

NCI-Approved Clinical Trials

December 29, 2006

Kennedy Chooses Health/Education Chair Over Judiciary; No Major Changes In Senate Cancer Policies Expected

November 14, 1986

DCT Board Agrees To Use Of Program Announcement For New Surgery Grants

March 13, 1981